chronic insomnia disorder
Conditions
Interventions
Zopiclone treatment group:None
rTMS intervention combined with zopiclone group:rTMS intervention combined with zopiclone treatment
Sponsors
Xiangyang Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.Select 100 patients aged 18-60 years who have a confirmed diagnosis of chronic insomnia disorder and are receiving treatment at the Neurology Department of Xiangyang Central Hospital. The patients should have a disease duration of at least 3 months, and the use of sedative-hypnotic medications should not exceed 4 times per week. 2.Primary school and above education level; 3.Right-hander; 4.No organic lesions were found in the head MR;
Exclusion criteria
Exclusion criteria: 1.Secondary insomnia caused by physical diseases, drugs and other reasons; 2.Pregnant and lactating women, alcohol or drug dependence, etc.; 3.MR examination taboos; 4.Those who refuse to sign the informed consent form for treatment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness of rTMS intervention combined with zopiclone in treating patients with chronic insomnia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Neuroimaging markers of patients with chronic insomnia treated with rTMS intervention combined with zopiclone; | — |
Countries
China
Contacts
Public ContactShang Furong
Xiangyang Central Hospital
Outcome results
None listed